Results 181 to 190 of about 11,286 (211)
Some of the next articles are maybe not open access.

Butyrylcholinesterase deficiency

Annales de biologie clinique, 2016
Butyrylcholinesterase (EC 3.1.1.8; BChE) is a sister enzyme of acetylcholinesterase. Though BChE lacks obvious physiological functions, it is of toxicological and pharmacological importance in detoxifying or catabolising ester-containing drugs. Furthermore, individuals deficient in BChE appear asymptomatic, apart from a heightened sensitivity to the ...
Hervé, Delacour   +4 more
openaire   +2 more sources

Neurobiology of butyrylcholinesterase

Nature Reviews Neuroscience, 2003
Butyrylcholinesterase is a serine hydrolase related to acetylcholinesterase that catalyses the hydrolysis of esters of choline, including acetylcholine. Butyrylcholinesterase has unique enzymatic properties and is widely distributed in the nervous system, pointing to its possible involvement in neural function.
Sultan, Darvesh   +2 more
openaire   +2 more sources

Butyrylcholinesterase in metabolic syndrome

Medical Hypotheses, 2010
Butyrylcholinesterase may have a role in a number of metabolic functions and could affect the expression of insulin resistance syndrome. We present our integrated work using clinical, biochemical and bioinformatic approaches to delineate the possible function of this enzyme.
Gumpeny R, Sridhar   +11 more
openaire   +2 more sources

Butyrylcholinesterase formulated in liposomes

Biotechnology and Applied Biochemistry, 1999
Exogenous cholinesterases have the potential to take part in defence against organophosphate toxins, by acting as scavenger systems. Postulating that formulation in liposomes could enhance the toxin‐scavenging potential of these enzymes, we have initiated studies of such formulations and are reporting here our first steps, exploring ...
I, Schumacher, A, Arad, R, Margalit
openaire   +2 more sources

‘Inverse’ substrates for butyrylcholinesterase

Biochimica et Biophysica Acta (BBA) - Enzymology, 1980
1. 'Inverse'-type substrates for butyrylcholinesterase (acylcholine acylhydrolase, EC 3.1.1.8), i.e., p- and o-nitrophenyl esters of (3-carboxypropyl)-trimethylammonium iodide, (4-carboxybutyl)trimethylammonium iodide and (5-carboxypentyl)trimethylammonium iodide were prepared, and their kinetic parameters for butyrylcholinesterase-catalyzed hydrolysis
M, Nozawa, K, Tanizawa, Y, Kanaoka
openaire   +2 more sources

Resveratrol Derived Butyrylcholinesterase Inhibitors

Archiv der Pharmazie, 2013
Novel polyhydroxylated (E)‐stilbenes were synthesized by Mizoroki–Heck reactions and tested for their ability to inhibit the enzymes acetyl‐ and butyrylcholinesterase. Several of them are good inhibitors of butyrylcholinesterase; one of them carrying an extra fluorine substituent is a 94‐fold stronger inhibitor of butyrylcholinesterase than of ...
René, Csuk   +3 more
openaire   +2 more sources

Imaging Butyrylcholinesterase in Multiple Sclerosis

Molecular Imaging and Biology, 2020
Molecular imaging agents targeting butyrylcholinesterase (BChE) have shown promise in other neurodegenerative disorders and may have utility in detecting changes to normal appearing white matter in multiple sclerosis (MS). BChE activity is present in white matter and localizes to activated microglia associated with MS lesions. The purpose of this study
M. W. D. Thorne   +6 more
openaire   +2 more sources

A mechanistic model for butyrylcholinesterase

Biochimica et Biophysica Acta (BBA) - Enzymology, 1979
A plausible mechanism of action of horse serum butyrylcholinesterase is proposed. It includes substrate activation at the level of deacylation. The rate constant for the acylation of the enzyme appears to be much greater than the rate constant for the deacylation, at low substate concentrations.
H, Eriksson, K B, Augustinsson
openaire   +2 more sources

Home - About - Disclaimer - Privacy